Follow-Up – Fall 2018

Research doesn’t stop when we report it. Here is an update on a past UConn Health Journal stories:


Glycogen Storage Disease

Dr. Annabelle Rodriguez-Oquendo, professor of cell biology at the UConn School of Medicine, was recently issued a diagnostic patent to test for a genetic predisposition for an abnormal inflammatory response that causes several life-threatening disorders, like coronary artery disease and chronic inflammatory disease. Lipid Genomics, the start-up Rodriguez-Oquendo founded in 2010, has exclusively licensed the technology from UConn Health. The company is currently in discussion with potential investors to continue commercialization of this product, as well as other therapeutic innovations for HDL-cholesterol dysfunction.

Winter 2015, “Getting to the Heart of the Matter”


Related Articles

  • Trauma Director Puts Patients First

    Dr. Ryan Millea hasn’t lost focus on what drives him, whether responding at a moment’s notice to the surgical needs of a car accident victim or to an intensive care patient with a life-threatening gastrointestinal burst.

  • Curators Versus Cancer

    A special team of medical literature experts are on the hunt for cancer’s kryptonite, one mutation at a time.

  • Got Breast Milk?

    UConn John Dempsey Hospital is the only location in Greater Hartford accepting breast milk donations for newborns in need.

  • Connecticut Student Researchers Shine

    The first class of Partnership for Innovation and Education summer fellows showcased their projects at the inaugural Innovation Fellows Research Day.